Eleven Biotherapeutics

Ownership Profile
Shareholder Breakdown
Shareholder Holders Values ($) % O/S Shares
Institution 41 30 55.07 13,602,114
Mutual Fund 11 0 0.90 222,138
Institutional Shareholder Rotation
Shareholder Holders Values Change ($) % O/S Shares Change
Buyers 18 1.82 3.67 907,259
Sellers 19 -4.00 7.29 -1,799,820
Net -- -2.19 3.62 -892,561
Institutional Shareholder Concentration
Shareholder Values ($) % O/S Shares
Top 10 Inst. 29 52.03 12,852,502
Top 20 Inst. 30.06 54.49 13,459,234
Top 50 Inst. 30.35 55.07 13,602,114
Total Inst. 30.35 55.07 13,602,114
Institutional Shareholder Style
Shareholder Holders Values ($) % O/S Shares
Index 6 1 2.70 667,549
TotalGrowth 4 0 0.14 33,479
TotalIncome 1 0 0.02 3,758
TotalOther 17 16 33.32 8,230,612
CoreValue 1 0 0.00 100
Top Holders: Institutional Investor
Holder Shares Held % O/S Shares Change Filing Date
Third Rock Ventures, LLC 4,841,591 19.60 0 06/30/2016
Clairmark Investments, Ltd. 3,582,328 14.50 3,582,328 09/20/2016
JAFCO Co., Ltd. 1,449,337 5.87 -507,289 12/31/2015
Flagship Ventures 1,066,451 4.32 -257,567 04/05/2017
BlackRock Institutional Trust Company, N.A. 444,450 1.80 63,557 12/31/2016
Hurly (Stephen A.) 398,031 1.61 398,031 09/20/2016
Celniker (Abbie C) 381,315 1.54 -10,031 09/28/2016
Sabby Management, LLC 348,893 1.41 348,893 12/31/2016
OxFORD Asset Management 179,627 0.73 179,627 12/31/2016
Furfine (Eric Steven) 160,479 0.65 160,479 06/30/2016
Spark Investment Management LLC 140,500 0.57 140,500 12/31/2016
The Vanguard Group, Inc. 121,156 0.49 7,500 12/31/2016
Lynch (Daniel S) 70,879 0.29 0 06/30/2016
Broadfin Capital, L.L.C. 54,450 0.22 54,450 12/31/2015
Acrospire Investment Management LLC 53,422 0.22 34,322 12/31/2016
Geode Capital Management, L.L.C. 46,887 0.19 200 12/31/2016
Mellon Capital Management Corporation 36,600 0.15 0 12/31/2016
KCG Americas LLC 29,478 0.12 -68,500 12/31/2016
T. Rowe Price Associates, Inc. 28,200 0.11 0 12/31/2016
Airain Ltd 25,160 0.10 12,080 12/31/2016
Eagle Global Advisors, LLC 21,602 0.09 21,602 12/31/2016
Tubridy (Karen L) 20,286 0.08 20,286 06/30/2016
Auriga Global Investors Sociedad de Valores, S.A. 19,527 0.08 19,527 12/31/2015
Northern Trust Investments, Inc. 17,975 0.07 162 12/31/2016
Susquehanna Financial Group, LLLP 15,586 0.06 -20,954 12/31/2016
Credit Suisse Securities (USA) LLC 14,860 0.06 14,860 12/31/2016
Fiduciary Trust Company 10,000 0.04 0 12/31/2016
BMO Capital Markets (US) 5,000 0.02 5,000 03/31/2017
BNY Mellon Asset Management 3,758 0.02 -178 12/31/2016
FNY Partners Fund LP 3,000 0.01 3,000 12/31/2016
McCabe (John J) 2,597 0.01 -1,399 02/14/2017
Morgan Stanley & Co. LLC 2,204 0.01 966 12/31/2016
Morgan Stanley Wealth Management 1,876 0.01 -1,350 12/31/2016
Cutler Group, LP 1,114 0.00 -100 03/31/2017
Advantage Investment Management, LLC 1,000 0.00 0 12/31/2016
Independent Financial Partners 1,000 0.00 1,000 12/31/2016
RBC Capital Markets Wealth Management 500 0.00 0 12/31/2016
Citi Investment Research (US) 500 0.00 -100 12/31/2016
UBS Financial Services, Inc. 481 0.00 -9,264 12/31/2016
Barclays Capital Inc. 13 0.00 13 12/31/2016
Northern Trust Global Investments 1 0.00 0 12/31/2016

Ownership data is provided by Thomson Reuters, a third party service, and Eleven Biotherapeutics does not maintain or provide information directly to this service.

NASDAQ: EBIO
Price:
1.92
Change:
0.00
Day High:
1.96
Day Low:
1.90
Volume:
89,430
4:00 PM ET on April 26, 2017
Delayed at least 20 minutes.